内免疫疗法的信心！我国生物技术公司ICT CAR-T治疗B淋巴细胞白血病治愈率达90%

2016-05-10 佚名生物谷

图片来源：http://www.biospace.com 4月22日至24日，2016年血液病免疫治疗峰会在杭州召开。来自浙江大学附属第一医院的黄河教授首次公开了10个CAR-T治疗白血病的临床病例数据，成果非常喜人。该临床试验是由浙江大学附属第一医院协同生物技术公司Innovative Cellular Therapeutics (ICT)联合实施的，2015年6月份通过伦理委员会批准

图片来源：http://www.biospace.com

4月22日至24日，2016年血液病免疫治疗峰会在杭州召开。来自浙江大学附属第一医院的黄河教授首次公开了10个CAR-T治疗白血病的临床病例数据，成果非常喜人。

该临床试验是由浙江大学附属第一医院协同生物技术公司Innovative Cellular Therapeutics (ICT)联合实施的，2015年6月份通过伦理委员会批准，接受了首例患者。到2016年4月，第十名患者获得了完全缓解。在为期10个月的临床试验中，黄河研究团队为这10名复发或难治性B淋巴细胞白血病患者进行了CAR-T细胞治疗，并初步评估其安全性和有效性。

该临床试验严格符合临床伦理标准，并由第三方临床研究机构监督。所有接受CAR-T治疗的患者产生的医疗费用由Innovative Cellular Therapeutics (ICT)公司承担。试验结果表明，9名患者获得了完全缓解，8名患者的白血病微小残留病（minimal residual disease，MRD）转为阴性，这是CAR-T治疗取得疗效的重要标志。白血病微小残留病，是指在白血病经诱导化疗获完全缓解后或是骨髓移植治疗后，体内仍雍留有少量白血病细胞的状态，可作为预后的一个指标。90%的完全缓解率、80%的MRD阴性率，这是迄今为止世界上用CAR-T治疗B淋巴细胞白血病得到的最佳结果。

这10名参与临床治疗的患者，年龄从17岁至57岁，全部患有复发或难治性B淋巴细胞白血病，接受治疗前，生命只剩下短短的几个月。参与临床治疗的第十名患者年仅17岁，她于今年3月份决定接受CAR-T治疗。黄河研究团队从她的血液中分离出T细胞，并对其进行基因工程改造，使其表达嵌合抗原受体，也就是所谓的“CAR”。表达嵌合抗原受体的T细胞能够准确识别和消灭恶性肿瘤细胞，从而达到治疗癌症的目的。随后4月份，CAR-T细胞被重新输入患者体内，接着就发生了“细胞因子风暴”，这是研究人员预期的结果。由于CAR-T细胞在患者体内快速增殖，机体会释放大量的细胞因子，患者会出现发热、肌肉疼痛和血氧不足等症状，这表明CAR-T细胞在体内发挥了作用。最终结果是这名17岁的患者获得了完全缓解，其白血病微小残留病也转为阴性。

Innovative Cellular Therapeutics公司除了与浙江大学第一附属医院进行合作之外，还与其它7家医院展开了复发和难治性急性淋巴细胞白血病的CAR-T治疗临床试验，目前这部分临床试验已经完成，得到了23名患者的原始数据。这23名患者中，有20名得到了完全缓解，完全缓解率达到87%。

在此之前，全世界只有诺华、Juno和Kite Pharma这三家美国公司在白血病中开展了类似的CAR-T治疗。这次临床试验成功标志着Innovative Cellular Therapeutics在CAR-T治疗白血病方面达到了世界领先水平。接下来，Innovative Cellular Therapeutics还将开展CAR-T治疗淋巴瘤的临床试验。随后Innovative Cellular Therapeutics将把目光投向结直肠癌、胃癌、食道癌等实体瘤领域。

近年来，CAR-T治疗已经受到医生、研究人员和患者的充分关注，作为一项精准的肿瘤免疫疗法，相信会在未来使得更多的肿瘤患者受益。谈到这里，生物谷小编想补充的是，这则消息许多外媒纷纷进行了报道，而国内却鲜有报道，不知是否受到了“魏则西事件”的影响。肿瘤免疫治疗在世界范围内方兴未艾，国内许多研究团队已经取得了一些成绩，例如李宗海教授的研究团队在恶性胶质瘤中进行的CAR-T治疗已经取得了喜人的成果。“魏则西事件”的黑锅不应当让肿瘤免疫疗法来背，人们需要相信国内科学家做出的努力，而不能让这一负面消息限制肿瘤免疫疗法在国内的发展。

原始出处：

Innovative Cellular Therapeutics Co.， Ltd. Release： Complete Remission Rate of 90： China-based CAR-T Cell Therapy Achieves Breakthrough Clinical Trial Results.2016.5.6

相关会议推荐

2016（第七届）细胞治疗国际研讨会

会议时间：2016.06.17-2016.06.18 会议地点：武汉

会议详情： http://www.bioon.com/z/2016Cell-therapies/

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言

评论区 (8)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1988740, encodeId=f7f41988e40d1, content=<a href='/topic/show?id=fada6455e8c' target=_blank style='color:#2F92EE;'>#治愈率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64557, encryptionId=fada6455e8c, topicName=治愈率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afa4194, createdName=cenghis, createdTime=Mon May 23 18:36:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1781107, encodeId=5cd71e8110718, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4059, encryptionId=8ce8405907, topicName=CAR-)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Aug 09 23:36:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020125, encodeId=7166202012587, content=<a href='/topic/show?id=c1ef38337f' target=_blank style='color:#2F92EE;'>#B淋巴细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3833, encryptionId=c1ef38337f, topicName=B淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Thu Dec 29 04:36:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755559, encodeId=8fc71e5555912, content=<a href='/topic/show?id=26a938319c' target=_blank style='color:#2F92EE;'>#B淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3831, encryptionId=26a938319c, topicName=B淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a9736969025, createdName=fengting15, createdTime=Sat May 21 12:36:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980907, encodeId=72dd198090ea2, content=<a href='/topic/show?id=7fe66934067' target=_blank style='color:#2F92EE;'>#生物技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69340, encryptionId=7fe66934067, topicName=生物技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f54230, createdName=xlysu, createdTime=Thu Mar 30 04:36:00 CST 2017, time=2017-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1997815, encodeId=9e66199e81565, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66001, encryptionId=75ff66001cd, topicName=淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Mon Jun 20 09:36:00 CST 2016, time=2016-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86752, encodeId=45f486e5270, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=149d1722688, createdName=1deccd6bm00(暂无匿称), createdTime=Sat May 21 11:09:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302024, encodeId=747e130202493, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65990, encryptionId=82a6659902c, topicName=淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Thu May 12 09:36:00 CST 2016, time=2016-05-12, status=1, ipAttribution=)]
2016-05-23 cenghis

#治愈率#

48 0
[GetPortalCommentsPageByObjectIdResponse(id=1988740, encodeId=f7f41988e40d1, content=<a href='/topic/show?id=fada6455e8c' target=_blank style='color:#2F92EE;'>#治愈率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64557, encryptionId=fada6455e8c, topicName=治愈率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afa4194, createdName=cenghis, createdTime=Mon May 23 18:36:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1781107, encodeId=5cd71e8110718, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4059, encryptionId=8ce8405907, topicName=CAR-)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Aug 09 23:36:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020125, encodeId=7166202012587, content=<a href='/topic/show?id=c1ef38337f' target=_blank style='color:#2F92EE;'>#B淋巴细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3833, encryptionId=c1ef38337f, topicName=B淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Thu Dec 29 04:36:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755559, encodeId=8fc71e5555912, content=<a href='/topic/show?id=26a938319c' target=_blank style='color:#2F92EE;'>#B淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3831, encryptionId=26a938319c, topicName=B淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a9736969025, createdName=fengting15, createdTime=Sat May 21 12:36:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980907, encodeId=72dd198090ea2, content=<a href='/topic/show?id=7fe66934067' target=_blank style='color:#2F92EE;'>#生物技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69340, encryptionId=7fe66934067, topicName=生物技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f54230, createdName=xlysu, createdTime=Thu Mar 30 04:36:00 CST 2017, time=2017-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1997815, encodeId=9e66199e81565, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66001, encryptionId=75ff66001cd, topicName=淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Mon Jun 20 09:36:00 CST 2016, time=2016-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86752, encodeId=45f486e5270, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=149d1722688, createdName=1deccd6bm00(暂无匿称), createdTime=Sat May 21 11:09:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302024, encodeId=747e130202493, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65990, encryptionId=82a6659902c, topicName=淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Thu May 12 09:36:00 CST 2016, time=2016-05-12, status=1, ipAttribution=)]
2016-08-09 仁者大医

#CAR-#

43 0
[GetPortalCommentsPageByObjectIdResponse(id=1988740, encodeId=f7f41988e40d1, content=<a href='/topic/show?id=fada6455e8c' target=_blank style='color:#2F92EE;'>#治愈率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64557, encryptionId=fada6455e8c, topicName=治愈率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afa4194, createdName=cenghis, createdTime=Mon May 23 18:36:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1781107, encodeId=5cd71e8110718, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4059, encryptionId=8ce8405907, topicName=CAR-)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Aug 09 23:36:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020125, encodeId=7166202012587, content=<a href='/topic/show?id=c1ef38337f' target=_blank style='color:#2F92EE;'>#B淋巴细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3833, encryptionId=c1ef38337f, topicName=B淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Thu Dec 29 04:36:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755559, encodeId=8fc71e5555912, content=<a href='/topic/show?id=26a938319c' target=_blank style='color:#2F92EE;'>#B淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3831, encryptionId=26a938319c, topicName=B淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a9736969025, createdName=fengting15, createdTime=Sat May 21 12:36:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980907, encodeId=72dd198090ea2, content=<a href='/topic/show?id=7fe66934067' target=_blank style='color:#2F92EE;'>#生物技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69340, encryptionId=7fe66934067, topicName=生物技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f54230, createdName=xlysu, createdTime=Thu Mar 30 04:36:00 CST 2017, time=2017-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1997815, encodeId=9e66199e81565, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66001, encryptionId=75ff66001cd, topicName=淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Mon Jun 20 09:36:00 CST 2016, time=2016-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86752, encodeId=45f486e5270, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=149d1722688, createdName=1deccd6bm00(暂无匿称), createdTime=Sat May 21 11:09:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302024, encodeId=747e130202493, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65990, encryptionId=82a6659902c, topicName=淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Thu May 12 09:36:00 CST 2016, time=2016-05-12, status=1, ipAttribution=)]
2016-12-29 ms3830150583600765

#B淋巴细胞白血病#

0 0
[GetPortalCommentsPageByObjectIdResponse(id=1988740, encodeId=f7f41988e40d1, content=<a href='/topic/show?id=fada6455e8c' target=_blank style='color:#2F92EE;'>#治愈率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64557, encryptionId=fada6455e8c, topicName=治愈率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afa4194, createdName=cenghis, createdTime=Mon May 23 18:36:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1781107, encodeId=5cd71e8110718, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4059, encryptionId=8ce8405907, topicName=CAR-)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Aug 09 23:36:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020125, encodeId=7166202012587, content=<a href='/topic/show?id=c1ef38337f' target=_blank style='color:#2F92EE;'>#B淋巴细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3833, encryptionId=c1ef38337f, topicName=B淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Thu Dec 29 04:36:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755559, encodeId=8fc71e5555912, content=<a href='/topic/show?id=26a938319c' target=_blank style='color:#2F92EE;'>#B淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3831, encryptionId=26a938319c, topicName=B淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a9736969025, createdName=fengting15, createdTime=Sat May 21 12:36:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980907, encodeId=72dd198090ea2, content=<a href='/topic/show?id=7fe66934067' target=_blank style='color:#2F92EE;'>#生物技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69340, encryptionId=7fe66934067, topicName=生物技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f54230, createdName=xlysu, createdTime=Thu Mar 30 04:36:00 CST 2017, time=2017-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1997815, encodeId=9e66199e81565, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66001, encryptionId=75ff66001cd, topicName=淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Mon Jun 20 09:36:00 CST 2016, time=2016-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86752, encodeId=45f486e5270, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=149d1722688, createdName=1deccd6bm00(暂无匿称), createdTime=Sat May 21 11:09:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302024, encodeId=747e130202493, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65990, encryptionId=82a6659902c, topicName=淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Thu May 12 09:36:00 CST 2016, time=2016-05-12, status=1, ipAttribution=)]
2016-05-21 fengting15

#B淋巴细胞#

49 0
[GetPortalCommentsPageByObjectIdResponse(id=1988740, encodeId=f7f41988e40d1, content=<a href='/topic/show?id=fada6455e8c' target=_blank style='color:#2F92EE;'>#治愈率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64557, encryptionId=fada6455e8c, topicName=治愈率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afa4194, createdName=cenghis, createdTime=Mon May 23 18:36:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1781107, encodeId=5cd71e8110718, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4059, encryptionId=8ce8405907, topicName=CAR-)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Aug 09 23:36:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020125, encodeId=7166202012587, content=<a href='/topic/show?id=c1ef38337f' target=_blank style='color:#2F92EE;'>#B淋巴细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3833, encryptionId=c1ef38337f, topicName=B淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Thu Dec 29 04:36:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755559, encodeId=8fc71e5555912, content=<a href='/topic/show?id=26a938319c' target=_blank style='color:#2F92EE;'>#B淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3831, encryptionId=26a938319c, topicName=B淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a9736969025, createdName=fengting15, createdTime=Sat May 21 12:36:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980907, encodeId=72dd198090ea2, content=<a href='/topic/show?id=7fe66934067' target=_blank style='color:#2F92EE;'>#生物技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69340, encryptionId=7fe66934067, topicName=生物技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f54230, createdName=xlysu, createdTime=Thu Mar 30 04:36:00 CST 2017, time=2017-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1997815, encodeId=9e66199e81565, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66001, encryptionId=75ff66001cd, topicName=淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Mon Jun 20 09:36:00 CST 2016, time=2016-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86752, encodeId=45f486e5270, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=149d1722688, createdName=1deccd6bm00(暂无匿称), createdTime=Sat May 21 11:09:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302024, encodeId=747e130202493, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65990, encryptionId=82a6659902c, topicName=淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Thu May 12 09:36:00 CST 2016, time=2016-05-12, status=1, ipAttribution=)]
2017-03-30 xlysu

#生物技术#

37 0
[GetPortalCommentsPageByObjectIdResponse(id=1988740, encodeId=f7f41988e40d1, content=<a href='/topic/show?id=fada6455e8c' target=_blank style='color:#2F92EE;'>#治愈率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64557, encryptionId=fada6455e8c, topicName=治愈率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afa4194, createdName=cenghis, createdTime=Mon May 23 18:36:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1781107, encodeId=5cd71e8110718, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4059, encryptionId=8ce8405907, topicName=CAR-)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Aug 09 23:36:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020125, encodeId=7166202012587, content=<a href='/topic/show?id=c1ef38337f' target=_blank style='color:#2F92EE;'>#B淋巴细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3833, encryptionId=c1ef38337f, topicName=B淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Thu Dec 29 04:36:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755559, encodeId=8fc71e5555912, content=<a href='/topic/show?id=26a938319c' target=_blank style='color:#2F92EE;'>#B淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3831, encryptionId=26a938319c, topicName=B淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a9736969025, createdName=fengting15, createdTime=Sat May 21 12:36:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980907, encodeId=72dd198090ea2, content=<a href='/topic/show?id=7fe66934067' target=_blank style='color:#2F92EE;'>#生物技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69340, encryptionId=7fe66934067, topicName=生物技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f54230, createdName=xlysu, createdTime=Thu Mar 30 04:36:00 CST 2017, time=2017-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1997815, encodeId=9e66199e81565, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66001, encryptionId=75ff66001cd, topicName=淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Mon Jun 20 09:36:00 CST 2016, time=2016-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86752, encodeId=45f486e5270, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=149d1722688, createdName=1deccd6bm00(暂无匿称), createdTime=Sat May 21 11:09:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302024, encodeId=747e130202493, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65990, encryptionId=82a6659902c, topicName=淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Thu May 12 09:36:00 CST 2016, time=2016-05-12, status=1, ipAttribution=)]
2016-06-20 仁者大医

#淋巴细胞白血病#

30 0
[GetPortalCommentsPageByObjectIdResponse(id=1988740, encodeId=f7f41988e40d1, content=<a href='/topic/show?id=fada6455e8c' target=_blank style='color:#2F92EE;'>#治愈率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64557, encryptionId=fada6455e8c, topicName=治愈率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afa4194, createdName=cenghis, createdTime=Mon May 23 18:36:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1781107, encodeId=5cd71e8110718, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4059, encryptionId=8ce8405907, topicName=CAR-)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Aug 09 23:36:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020125, encodeId=7166202012587, content=<a href='/topic/show?id=c1ef38337f' target=_blank style='color:#2F92EE;'>#B淋巴细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3833, encryptionId=c1ef38337f, topicName=B淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Thu Dec 29 04:36:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755559, encodeId=8fc71e5555912, content=<a href='/topic/show?id=26a938319c' target=_blank style='color:#2F92EE;'>#B淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3831, encryptionId=26a938319c, topicName=B淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a9736969025, createdName=fengting15, createdTime=Sat May 21 12:36:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980907, encodeId=72dd198090ea2, content=<a href='/topic/show?id=7fe66934067' target=_blank style='color:#2F92EE;'>#生物技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69340, encryptionId=7fe66934067, topicName=生物技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f54230, createdName=xlysu, createdTime=Thu Mar 30 04:36:00 CST 2017, time=2017-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1997815, encodeId=9e66199e81565, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66001, encryptionId=75ff66001cd, topicName=淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Mon Jun 20 09:36:00 CST 2016, time=2016-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86752, encodeId=45f486e5270, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=149d1722688, createdName=1deccd6bm00(暂无匿称), createdTime=Sat May 21 11:09:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302024, encodeId=747e130202493, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65990, encryptionId=82a6659902c, topicName=淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Thu May 12 09:36:00 CST 2016, time=2016-05-12, status=1, ipAttribution=)]
2016-05-21 1deccd6bm00(暂无匿称)

值得关注

121 0
[GetPortalCommentsPageByObjectIdResponse(id=1988740, encodeId=f7f41988e40d1, content=<a href='/topic/show?id=fada6455e8c' target=_blank style='color:#2F92EE;'>#治愈率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64557, encryptionId=fada6455e8c, topicName=治愈率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afa4194, createdName=cenghis, createdTime=Mon May 23 18:36:00 CST 2016, time=2016-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1781107, encodeId=5cd71e8110718, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4059, encryptionId=8ce8405907, topicName=CAR-)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Aug 09 23:36:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020125, encodeId=7166202012587, content=<a href='/topic/show?id=c1ef38337f' target=_blank style='color:#2F92EE;'>#B淋巴细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3833, encryptionId=c1ef38337f, topicName=B淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Thu Dec 29 04:36:00 CST 2016, time=2016-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755559, encodeId=8fc71e5555912, content=<a href='/topic/show?id=26a938319c' target=_blank style='color:#2F92EE;'>#B淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3831, encryptionId=26a938319c, topicName=B淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a9736969025, createdName=fengting15, createdTime=Sat May 21 12:36:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980907, encodeId=72dd198090ea2, content=<a href='/topic/show?id=7fe66934067' target=_blank style='color:#2F92EE;'>#生物技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69340, encryptionId=7fe66934067, topicName=生物技术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f54230, createdName=xlysu, createdTime=Thu Mar 30 04:36:00 CST 2017, time=2017-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1997815, encodeId=9e66199e81565, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66001, encryptionId=75ff66001cd, topicName=淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Mon Jun 20 09:36:00 CST 2016, time=2016-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86752, encodeId=45f486e5270, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=149d1722688, createdName=1deccd6bm00(暂无匿称), createdTime=Sat May 21 11:09:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1302024, encodeId=747e130202493, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65990, encryptionId=82a6659902c, topicName=淋巴细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Thu May 12 09:36:00 CST 2016, time=2016-05-12, status=1, ipAttribution=)]
2016-05-12 wetgdt

#淋巴细胞#

26 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤科

内免疫疗法的信心！我国生物技术公司ICT CAR-T治疗B淋巴细胞白血病治愈率达90%

相关资讯

科室

工具

服务